These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Experimental models of sepsis and their clinical relevance. Poli-de-Figueiredo LF; Garrido AG; Nakagawa N; Sannomiya P Shock; 2008 Oct; 30 Suppl 1():53-9. PubMed ID: 18704008 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release. Vianna RC; Gomes RN; Bozza FA; Amâncio RT; Bozza PT; David CM; Castro-Faria-Neto HC Shock; 2004 Feb; 21(2):115-20. PubMed ID: 14752283 [TBL] [Abstract][Full Text] [Related]
5. The disconnect between animal models of sepsis and human sepsis. Rittirsch D; Hoesel LM; Ward PA J Leukoc Biol; 2007 Jan; 81(1):137-43. PubMed ID: 17020929 [TBL] [Abstract][Full Text] [Related]
6. Murine model of polymicrobial septic peritonitis using cecal ligation and puncture (CLP). Medina E Methods Mol Biol; 2010; 602():411-5. PubMed ID: 20012411 [TBL] [Abstract][Full Text] [Related]
7. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Dyson A; Singer M Crit Care Med; 2009 Jan; 37(1 Suppl):S30-7. PubMed ID: 19104223 [TBL] [Abstract][Full Text] [Related]
9. Sophorolipids improve sepsis survival: effects of dosing and derivatives. Hardin R; Pierre J; Schulze R; Mueller CM; Fu SL; Wallner SR; Stanek A; Shah V; Gross RA; Weedon J; Nowakowski M; Zenilman ME; Bluth MH J Surg Res; 2007 Oct; 142(2):314-9. PubMed ID: 17719064 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis. Dunn DL; Bogard WC; Cerra FB Surgery; 1985 Aug; 98(2):283-90. PubMed ID: 3895540 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of hypertonic saline on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats. Shih CC; Chen SJ; Chen A; Wu JY; Liaw WJ; Wu CC Crit Care Med; 2008 Jun; 36(6):1864-72. PubMed ID: 18496380 [TBL] [Abstract][Full Text] [Related]
12. Development of an anti-core lipopolysaccharide vaccine for the prevention and treatment of sepsis. Cross AS; Opal S; Cook P; Drabick J; Bhattacharjee A Vaccine; 2004 Feb; 22(7):812-7. PubMed ID: 15040932 [TBL] [Abstract][Full Text] [Related]
13. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Siddiqui AM; Cui X; Wu R; Dong W; Zhou M; Hu M; Simms HH; Wang P Crit Care Med; 2006 Jul; 34(7):1874-82. PubMed ID: 16715036 [TBL] [Abstract][Full Text] [Related]
14. Cecal ligation and incision: an acute onset model of severe sepsis in rats. Scheiermann P; Hoegl S; Revermann M; Ahluwalia D; Zander J; Boost KA; Nguyen T; Zwissler B; Muhl H; Hofstetter C J Surg Res; 2009 Jan; 151(1):132-7. PubMed ID: 18486152 [TBL] [Abstract][Full Text] [Related]
15. Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms. Opal SM; Palardy JE; Chen WH; Parejo NA; Bhattacharjee AK; Cross AS J Infect Dis; 2005 Dec; 192(12):2074-80. PubMed ID: 16288370 [TBL] [Abstract][Full Text] [Related]